Renal Denervation Prevents Atrial Arrhythmogenic Substrate Development in CKD.
Mathias HohlSimina-Ramona SelejanJan WintrichUlrike LehnertThimoteus SpeerClara SchneiderMuriel MauzPhilipp MarkwirthDickson W L WongPeter BoorAndrey KazakovMartin MollenhauerBenedikt LinzBarbara Mara KlinkhammerUlrich HübnerChristian UkenaJulia MoellmannMichael LehrkeStefan WagenpfeilChristian WernerDominik K LinzFelix MahfoudMichael BöhmPublished in: Circulation research (2022)
In an experimental rat model of CKD, RDN inhibited progression of atrial structural and electrophysiological remodeling. Therefore, RDN represents a potential therapeutic tool to reduce the risk of AF in CKD, independent of changes in renal function and blood pressure.